Cas:646989-36-8 1-Chloro-5-methoxy-4-nitro-2-(trifluoromethyl)benzene manufacturer & supplier

We serve Chemical Name:1-Chloro-5-methoxy-4-nitro-2-(trifluoromethyl)benzene CAS:646989-36-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Chloro-5-methoxy-4-nitro-2-(trifluoromethyl)benzene

Chemical Name:1-Chloro-5-methoxy-4-nitro-2-(trifluoromethyl)benzene
CAS.NO:646989-36-8
Synonyms:Benzene, 1-chloro-5-methoxy-4-nitro-2-(trifluoromethyl)-;1-Chloro-5-methoxy-4-nitro-2-(trifluoromethyl)benzene;2-Chloro-4-methoxy-5-nitrobenzotrifluoride
Molecular Formula:C8H5ClF3NO3
Molecular Weight:255.578
HS Code:2909309090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:291.3±40.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.490
PSA:55.05000
Exact Mass:254.991013
LogP:4.12

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzene, 1-chloro-5-methoxy-4-nitro-2-(trifluoromethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-4-methoxy-5-nitrobenzotrifluoride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene, 1-chloro-5-methoxy-4-nitro-2-(trifluoromethyl)- Use and application,1-Chloro-5-methoxy-4-nitro-2-(trifluoromethyl)benzene technical grade,usp/ep/jp grade.


Related News: The analysis examined disease manifestations in the two most commonly impacted organ domains in SLE. Anifrolumab is a potential first-in-class type I interferon inhibitor. Methyl 4,6,7-trimethoxy-8-methyl-2-naphthoate manufacturers The company pinpointed Thousand Oaks for its expansion “based on capability, staffing as well as the local community and the things we could bring to the area,” Hatke, told the news outlet. 1-(benzenesulfonyl)-5-methylpyrrolo[2,3-b]pyridine suppliers Earlier this month, the drugmaker lifted a voluntary EU marketing hold on Zynteglo for beta thalassemia, after a patient death in one of the drugmaker’s other products, LentiGlobin, halted clinical studies. maleamic acid vendor & factory.